Please check your internet connection and try again.
# Mylot%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at
## Overview
Mylot%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at is a brand name for a medication containing **atorvastatin**. Atorvastatin is a HMG-CoA reductase inhibitor (statin) used to lower cholesterol levels.
## Primary Indications
* Hyperlipidemia: Adjunct to diet to reduce elevated total-C, LDL-C, and triglyceride levels and to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia.
* Prevention of Cardiovascular Disease: To reduce the risk of myocardial infarction and stroke in patients with multiple risk factors for coronary heart disease.
## Adult Dosing
* **Hyperlipidemia:**
* Starting dose: 10 mg to 20 mg orally once daily.
* Titration: Doses can be individualized from 10 mg to 80 mg once daily.
* Maximum dose: 80 mg once daily.
* **Prevention of Cardiovascular Disease:**
* Dose: 10 mg to 80 mg orally once daily.
## Pediatric Dosing
* Pediatric dosing is not well established for atorvastatin. Consult specific pediatric guidelines or expert consultation.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Moderate to severe hepatic impairment may require dose reduction or discontinuation. Patients with active liver disease or unexplained persistent elevations of serum transaminases should not receive atorvastatin.
* **Renal Impairment:** No dose adjustment is generally needed.
## Contraindications
* Active liver disease or unexplained persistent elevations of serum transaminases exceeding 3 times the upper limit of normal.
* Hypersensitivity to any component of this medication.
* Pregnancy and breastfeeding.
## Adverse Effects
* **Common:** Diarrhea, nausea, muscle aches (myalgia), joint pain (arthralgia), headache, nasopharyngitis.
* **Serious:** Myopathy (including rhabdomyolysis), hepatotoxicity, hyperglycemia, memory impairment/confusion.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** Cyclosporine, telithromycin, clarithromycin, ketoconazole, ritonavir, itraconazole. Increased risk of myopathy and rhabdomyolysis. Consider dose reduction or avoidance of atorvastatin.
* **Gemfibrozil and other fibrates:** Increased risk of myopathy and rhabdomyolysis. Avoid concomitant use.
* **Colchicine:** Increased risk of myopathy and rhabdomyolysis. Use with caution.
* **Warfarin:** May increase INR. Monitor INR closely when initiating or increasing atorvastatin dose.
* **Oral Contraceptives:** May increase plasma concentrations of oral contraceptives.
## Monitoring
* **Liver Function Tests (LFTs):** Baseline and periodically as clinically indicated. If signs or symptoms of liver injury occur, LFTs should be obtained immediately.
* **Creatine Kinase (CK):** Baseline and periodically as clinically indicated, especially in patients with risk factors for myopathy.
* **Lipid Panel:** Prior to initiating therapy and at 4-12 weeks after initiation or titration to assess efficacy.
* **Glucose Levels:** Monitor for hyperglycemia, especially in patients with diabetes.
## Clinical Pearls
* May be taken with or without food.
* Take at any time of day.
* Counsel patients to report unexplained muscle pain, tenderness, or weakness, especially if accompanied by malaise or fever.
* Consider the risk of myopathy, particularly when co-administered with other interacting medications.
* Grapefruit juice intake should be limited as it may increase atorvastatin concentrations.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols before making any clinical decisions.
